Close Menu
Arogidigba Global JournalArogidigba Global Journal
  • Home
  • Latest News
  • National
  • Politics
  • Entertainment
  • Sports

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

APC chieftain defends Senator Sani Musa over ‘harmonise’ controversy

May 31, 2025

Soludo’s wife disburses empowerment fund to over 1,000 petty traders

May 31, 2025

Abiodun mourns with Kano over athletes’ deaths in auto crash

May 31, 2025
Facebook X (Twitter) Instagram WhatsApp Telegram
  • About Us
  • Advert Rate
  • Get In Touch
Facebook X (Twitter) Instagram WhatsApp Telegram
Arogidigba Global JournalArogidigba Global Journal
  • Home
  • Latest News
  • National
  • Politics
  • Entertainment
  • Sports
Subscribe
Facebook X (Twitter) Instagram WhatsApp Telegram
Arogidigba Global JournalArogidigba Global Journal
You are at:Home»Health & Wellness»Sygen-ORX Biosciences, healthcare innovation promises access to life-saving treatments
Health & Wellness

Sygen-ORX Biosciences, healthcare innovation promises access to life-saving treatments

August 22, 2024No Comments4 Mins Read
Facebook Twitter Telegram LinkedIn WhatsApp Email Copy Link
Sygen-ORX Biosciences
Share
Facebook Twitter LinkedIn Email Telegram WhatsApp

SYGEN Pharmaceuticals and ORx Pharmaceuticals (Canada) have formed a new joint venture, Sygen-ORX Biosciences, with the intention of addressing local health needs by leveraging on innovation adapted to our environment.

The joint venture development, with academia, the private sector, and the government on board, intends to address local health needs by creating medicines based on pharmacogenetics and genetics that are within the reach of Nigerians while working with local companies.

Chief Executive Officer of Sygen Pharmaceuticals, Charles Ogunwuyi, speaking at a media briefing to announce the birth of the new joint venture, Sygen-ORX Biosciences in Lagos, declared that the Sygen Pharmaceuticals commercialisation expertise with ORx Pharmaceuticals (Canada) advanced research and development capabilities is intended to create impactful solutions in the continent.

Ogunwuyi added that local research and development and drug discovery based on pharmacogenetics is critical to the development of improved formulations of generic medicines, advancing innovative drug discovery programmes and reducing costs, and increasing access to high-quality generic medicines in Africa.

“The joint venture company will focus on the development of improved formulations of generic medicines, focussing on products that have already received regulatory approval and have achieved substantial commercial success.

“It is to advance innovative drug discovery programmes into the regional and global pharmaceutical markets and reduce costs and increase access to high-quality generic medicines in Africa,” he said.

Chief Executive Officer of ORx Pharmaceuticals (Canada), Dr Alexander MacGregor, said the partnership was leveraging Oryx’s intellectual property that was created over the last 30 years to develop effective and affordable medicines for Nigerians and other African countries.

Read Also: NNPC reports N9.3trn petrol imports amid fuel scarcity

“We have a suite of active pharmaceutical ingredients (IPAs) that we use to liberally develop a range of drugs without having to labour over things. One of the impediments to drug development is time. It’s like developing a recipe for making a variety of soups. So intellectual property-based allows you to leverage platform technologies.

“So, in the next three to four years you should expect to see innovative drugs within the essential medicines category right that are more affordable and are more effective for people in Nigeria and in Africa.

“Most of the drugs that we have here in Nigeria and Africa were not really developed with us in mind, and the genetics of Africans are different from the genetics of people in different parts of the world. So, it only makes it more important that you develop drugs based on our own genetics and social environmental factors.

“That will only not make it more effective, but it means you end up using lower dosage forms even as you end up localising that industry and making it less dependent on foreign importation. That in itself is going to be a major impact from a socio-economic and health standpoint.”

Earlier, Director General of the National Agency for Food and Drug Administration and Control, Professor Mojisola Adeyeye, described the joint venture as phenomenal in line with NAFDAC’s agenda to ensure Nigeria becomes less addicted to foreign-made products.

According to her, “We started with the manufacturers, that there must be a change in paradigm to ensure that we become less addictive to foreign-made products. That is what we started six years ago. In terms of telling ourselves that we can do it, to look inward.

“We are really embracing that paradigm change. The changes we are observing now in the industry are a reflection of the changes that are taking place in our country. If we are not strong ourselves, we cannot guide the manufacturers on how to meet international standards; how to use the quality management system approaches to ensure that the products that our people are getting are of quality, safe, and efficacious.”

Share. Facebook Twitter LinkedIn WhatsApp Email Telegram Copy Link
Previous ArticleNBA says domestic refining will address fuel scarcity, queues
Next Article Domestic refining will address fuel scarcity, queues — NBA 

Related Posts

Panic as strange disease kills six children in Imo

May 31, 2025

Menstrual Hygiene Day: UNICEF, Oyo govt engage 700 students on rights during menstruation

May 31, 2025

Firm partners NAPS to revolutionise healthcare services

May 31, 2025

Leave A Reply Cancel Reply

Ads />
</a></div>		</div>

		</div>
		<div id=
Latest Posts

APC chieftain defends Senator Sani Musa over ‘harmonise’ controversy

May 31, 20250 Views

Soludo’s wife disburses empowerment fund to over 1,000 petty traders

May 31, 20250 Views

Abiodun mourns with Kano over athletes’ deaths in auto crash

May 31, 20250 Views

Nigeria is in its biggest trouble since 1914 — El-Rufai

May 31, 20250 Views
Don't Miss

Danish Embassy, Danish Veterinary And Food Agency, Partner NAFDAC To Combat Antimicrobial Resisitance

By Arogidigba Global JournalDecember 8, 2024

The National Agency for Food and Drug Administration and Control NAFDAC in its quest to…

CAN disburses 600 baggage of rice to Jigawa Christians

January 6, 2024

Court Nullifies Rivers 2024 Budget, Bars Fubara From Interfering In Assembly Matters

January 22, 2024

OSIEC chairmanship: I am no longer PDP member – Hashim Abioye

January 12, 2024

Senate In Rowdy Session As Lawmaker Claims ‘Older’ Senators Got N500m For Projects

March 12, 2024
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo

Subscribe to Updates

Get the latest news from Arogidigba Global Journal

About Us
About Us

AROGIDIGBA GLOBAL NEWS…something of stupendous magnitude is a digital newspaper platform published by AROGIDIGBA MEDIA LIMITED. We are accessed all over the world on the various social media. As an independent News Organization, we are purposefully positioned to serve the Nigerian audience and the world with credible news reports and shrewd analyses.

Facebook X (Twitter) YouTube WhatsApp Reddit
Latest News

APC chieftain defends Senator Sani Musa over ‘harmonise’ controversy

May 31, 2025

Soludo’s wife disburses empowerment fund to over 1,000 petty traders

May 31, 2025

Nigeria is in its biggest trouble since 1914 — El-Rufai

May 31, 2025
Editor's Pick

Cardoso Named African Banker Central Bank Governor of the Year

May 30, 20250 Views

Running on empty: Power supply remains unreliable despite tariff hike- Poll

May 30, 20250 Views

Running on empty: Crops rot as farmers battle power cuts

May 30, 20250 Views
© 2025 Arogidigba Global Journal slot machine jackpot
  • Home
  • Latest News

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.